Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Pharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.

Larsen JB, Rasmussen JB.

Pharmgenomics Pers Med. 2017 Apr 18;10:115-128. doi: 10.2147/PGPM.S131580. eCollection 2017.

2.

National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China.

Lin G, Zhang K, Yi L, Han Y, Xie J, Li J.

PLoS One. 2016 Sep 7;11(9):e0162361. doi: 10.1371/journal.pone.0162361. eCollection 2016. Erratum in: PLoS One. 2016 Dec 1;11(12 ):e0167740.

3.

Development and Characterization of Reference Materials for Genetic Testing: Focus on Public Partnerships.

Kalman LV, Datta V, Williams M, Zook JM, Salit ML, Han JY.

Ann Lab Med. 2016 Nov;36(6):513-20. doi: 10.3343/alm.2016.36.6.513. Review.

4.

ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen.

Sensorn I, Sukasem C, Sirachainan E, Chamnanphon M, Pasomsub E, Trachu N, Supavilai P, Pinthong D, Wongwaisayawan S.

Onco Targets Ther. 2016 Apr 12;9:2121-9. doi: 10.2147/OTT.S100905. eCollection 2016.

5.

Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility.

Saldivar JS, Taylor D, Sugarman EA, Cullors A, Garces JA, Oades K, Centeno J.

Pharmgenomics Pers Med. 2016 Jan 19;9:1-6. doi: 10.2147/PGPM.S93480. eCollection 2016.

6.

Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China.

Yi L, Lin G, Zhang K, Wang L, Zhang R, Xie J, Li J.

PLoS One. 2016 Jan 28;11(1):e0148081. doi: 10.1371/journal.pone.0148081. eCollection 2016.

7.

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.

Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R, Liao J, Lorier R, Scott SA, Smith CH, Toji LH, Turner A, Kalman LV.

J Mol Diagn. 2016 Jan;18(1):109-23. doi: 10.1016/j.jmoldx.2015.08.005. Epub 2015 Nov 24.

8.

Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6.

Qiao W, Yang Y, Sebra R, Mendiratta G, Gaedigk A, Desnick RJ, Scott SA.

Hum Mutat. 2016 Mar;37(3):315-23. doi: 10.1002/humu.22936. Epub 2015 Dec 18.

9.

Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Kalman LV, Agúndez J, Appell ML, Black JL, Bell GC, Boukouvala S, Bruckner C, Bruford E, Caudle K, Coulthard SA, Daly AK, Del Tredici A, den Dunnen JT, Drozda K, Everts RE, Flockhart D, Freimuth RR, Gaedigk A, Hachad H, Hartshorne T, Ingelman-Sundberg M, Klein TE, Lauschke VM, Maglott DR, McLeod HL, McMillin GA, Meyer UA, Müller DJ, Nickerson DA, Oetting WS, Pacanowski M, Pratt VM, Relling MV, Roberts A, Rubinstein WS, Sangkuhl K, Schwab M, Scott SA, Sim SC, Thirumaran RK, Toji LH, Tyndale RF, van Schaik R, Whirl-Carrillo M, Yeo K, Zanger UM.

Clin Pharmacol Ther. 2016 Feb;99(2):172-85. doi: 10.1002/cpt.280. Epub 2015 Nov 20. Review.

10.

Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach.

Lin G, Yi L, Zhang K, Wang L, Zhang R, Xie J, Li J.

PLoS One. 2015 Jul 28;10(7):e0134174. doi: 10.1371/journal.pone.0134174. eCollection 2015.

11.

Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.

Numanagić I, Malikić S, Pratt VM, Skaar TC, Flockhart DA, Sahinalp SC.

Bioinformatics. 2015 Jun 15;31(12):i27-34. doi: 10.1093/bioinformatics/btv232.

12.

Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes.

Ammar R, Paton TA, Torti D, Shlien A, Bader GD.

Version 2. F1000Res. 2015 Jan 21 [revised 2015 Jan 1];4:17. doi: 10.12688/f1000research.6037.2. eCollection 2015.

13.

Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.

Smith T, Sharp S, Manzardo AM, Butler MG.

Int J Mol Sci. 2015 Feb 20;16(3):4416-28. doi: 10.3390/ijms16034416.

14.

A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.

Langaee T, Hamadeh I, Chapman AB, Gums JG, Johnson JA.

PLoS One. 2015 Jan 27;10(1):e0113808. doi: 10.1371/journal.pone.0113808. eCollection 2015.

15.

Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.

Pratt VM, Beyer BN, Koller DL, Skaar TC, Flockhart DA, Levy KD, Vance GH.

J Mol Diagn. 2015 Mar;17(2):201-5. doi: 10.1016/j.jmoldx.2014.11.005. Epub 2014 Dec 29.

16.

Implementation and utilization of genetic testing in personalized medicine.

Abul-Husn NS, Owusu Obeng A, Sanderson SC, Gottesman O, Scott SA.

Pharmgenomics Pers Med. 2014 Aug 13;7:227-40. doi: 10.2147/PGPM.S48887. eCollection 2014. Review.

17.

Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.

Fang H, Liu X, Ramírez J, Choudhury N, Kubo M, Im HK, Konkashbaev A, Cox NJ, Ratain MJ, Nakamura Y, O'Donnell PH.

Pharmacogenomics J. 2014 Dec;14(6):564-72. doi: 10.1038/tpj.2014.27. Epub 2014 Jul 1.

18.

Novel lymphoblastoid cell lines from primary neoplasms of the upper aero-digestive tract.

Katiyar S, Balani S, Singh V.

Indian J Med Res. 2012 Jun;135(6):803-5. No abstract available.

19.

Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Cacabelos R, Martínez R, Fernández-Novoa L, Carril JC, Lombardi V, Carrera I, Corzo L, Tellado I, Leszek J, McKay A, Takeda M.

Int J Alzheimers Dis. 2012;2012:518901. doi: 10.1155/2012/518901. Epub 2012 Mar 14.

20.

Bridging the gap: moving predictive and prognostic assays from research to clinical use.

Williams PM, Lively TG, Jessup JM, Conley BA.

Clin Cancer Res. 2012 Mar 15;18(6):1531-9. doi: 10.1158/1078-0432.CCR-11-2203.

Supplemental Content

Support Center